✦ LIBER ✦

Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neck

✍ Scribed by Jeffrey R. Jaglowski; Ian S. Zagon; Brendan C. Stack; Michael F. Verderame; Alphonse E. Leure-duPree; Jeffrey D. Manning; Patricia J. McLaughlin

Publisher: Springer
Year: 2005
Tongue: English
Weight: 257 KB
Volume: 56
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-004-0929-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Defects in the opioid growth factor rece

Defects in the opioid growth factor receptor in human squamous cell carcinoma of the head and neck

✍ Patricia J. McLaughlin; Brendan C. Stack Jr.; Roger J. Levin; Fred Fedok; Ian S. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 541 KB

## Abstract ## BACKGROUND The endogenous opioid peptide, [Met^5^]‐enkephalin, termed opioid growth factor (OGF), interacts with its receptor (OGFr) to play a role as a constitutively expressed inhibitory growth factor in the proliferation of epithelial cells. This study compared protein and gene e

Epidermal growth factor receptor targete

Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck

✍ Mark E. Sharafinski; Robert L. Ferris; Soldano Ferrone; Jennifer R. Grandis 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB 👁 2 views

## Abstract ## Background Cumulative evidence implicates the epidermal growth factor receptor (EGFR) as an important therapeutic target in head and neck squamous cell carcinoma (HNSCC). The basis for the lack of correlation between EGFR expression in the HNSCC tumor and clinical responses to EGFR

Expression profiles of angiogenic growth

Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck

✍ Simon Ninck; Christoph Reisser; Gerhard Dyckhoff; Burkhard Helmke; Harald Bauer; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 848 KB

## Abstract Inhibition of angiogenesis by blocking angiogenic cytokines or their pathways has become a major target in experimental cancer therapies. This therapeutical approach requires a profound knowledge of growth factor profiles that contribute to tumor growth and progression. The respective k

Inhibition of growth and survival of hum

Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-κB signaling

✍ Sita Aggarwal; Yasunari Takada; Sujay Singh; Jeffrey N. Myers; Bharat B. Aggarwa 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 971 KB

## Abstract Increased expression of proinflammatory and proangiogenic factors are associated with aggressive tumor growth and decreased survival of patients with head and neck squamous cell carcinoma (HNSCC). In as much as genes that are regulated by nuclear factor NF‐κB suppress apoptosis, induce

Gene amplification and overexpression of

Gene amplification and overexpression of epidermal growth factor receptor in squamous cell carcinoma of the head and neck

✍ Drs. Koichi Rikimaru; Drs. Keiko Tadokoro; Dr. Tadashi Yamamoto; Drs. Shoji Enom 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 552 KB

## Abstract The degree of gene amplification for epidermal growth factor receptor (EGFR) and its expression levels were examined in 4 cases of tumor lesions and their cell lines of human squamous cell carcinoma (SCC) of the oral cavity. The amplification was detected in 1 case (ZA), but not signifi

Vascular endothelial growth factor C and

Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck

✍ Csilla Neuchrist; Bohan M. Erovic; Allesandra Handisurya; Michael B. Fischer; Ge 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 379 KB 👁 1 views

## Abstract ## Background and Methods. VEGF proteins and their receptors are involved in tumor vessel neoformation. The third VEGF receptor, VEGFR3 (flt‐4) is important during both blood vessel development and lymphatic vessel formation. Because HNSCC preferentially metastasizes to regional lymph